Pharvaris Bv Stock Market Value

PHVS Stock  USD 23.69  1.40  6.28%   
Pharvaris' market value is the price at which a share of Pharvaris trades on a public exchange. It measures the collective expectations of Pharvaris BV investors about its performance. Pharvaris is selling for under 23.69 as of the 25th of November 2024; that is 6.28 percent up since the beginning of the trading day. The stock's lowest day price was 21.19.
With this module, you can estimate the performance of a buy and hold strategy of Pharvaris BV and determine expected loss or profit from investing in Pharvaris over a given investment horizon. Check out Pharvaris Correlation, Pharvaris Volatility and Pharvaris Alpha and Beta module to complement your research on Pharvaris.
Symbol

Pharvaris BV Price To Book Ratio

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pharvaris. If investors know Pharvaris will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pharvaris listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.72)
Return On Assets
(0.27)
Return On Equity
(0.45)
The market value of Pharvaris BV is measured differently than its book value, which is the value of Pharvaris that is recorded on the company's balance sheet. Investors also form their own opinion of Pharvaris' value that differs from its market value or its book value, called intrinsic value, which is Pharvaris' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pharvaris' market value can be influenced by many factors that don't directly affect Pharvaris' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pharvaris' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pharvaris is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pharvaris' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Pharvaris 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pharvaris' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pharvaris.
0.00
10/26/2024
No Change 0.00  0.0 
In 31 days
11/25/2024
0.00
If you would invest  0.00  in Pharvaris on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding Pharvaris BV or generate 0.0% return on investment in Pharvaris over 30 days. Pharvaris is related to or competes with Pmv Pharmaceuticals, Eliem Therapeutics, MediciNova, PepGen, Molecular Partners, Mineralys Therapeutics,, and AN2 Therapeutics. Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapie... More

Pharvaris Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pharvaris' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pharvaris BV upside and downside potential and time the market with a certain degree of confidence.

Pharvaris Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharvaris' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pharvaris' standard deviation. In reality, there are many statistical measures that can use Pharvaris historical prices to predict the future Pharvaris' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pharvaris' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
18.2922.2026.11
Details
Intrinsic
Valuation
LowRealHigh
17.2821.1925.10
Details
Naive
Forecast
LowNextHigh
19.2123.1227.03
Details
7 Analysts
Consensus
LowTargetHigh
21.9824.1526.81
Details

Pharvaris BV Backtested Returns

Pharvaris appears to be not too volatile, given 3 months investment horizon. Pharvaris BV maintains Sharpe Ratio (i.e., Efficiency) of 0.0937, which implies the firm had a 0.0937% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Pharvaris BV, which you can use to evaluate the volatility of the company. Please evaluate Pharvaris' Risk Adjusted Performance of 0.0822, semi deviation of 2.98, and Coefficient Of Variation of 1034.21 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Pharvaris holds a performance score of 7. The company holds a Beta of 1.28, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Pharvaris will likely underperform. Please check Pharvaris' potential upside, and the relationship between the jensen alpha and accumulation distribution , to make a quick decision on whether Pharvaris' historical price patterns will revert.

Auto-correlation

    
  -0.8  

Almost perfect reverse predictability

Pharvaris BV has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Pharvaris time series from 26th of October 2024 to 10th of November 2024 and 10th of November 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pharvaris BV price movement. The serial correlation of -0.8 indicates that around 80.0% of current Pharvaris price fluctuation can be explain by its past prices.
Correlation Coefficient-0.8
Spearman Rank Test-0.13
Residual Average0.0
Price Variance1.12

Pharvaris BV lagged returns against current returns

Autocorrelation, which is Pharvaris stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pharvaris' stock expected returns. We can calculate the autocorrelation of Pharvaris returns to help us make a trade decision. For example, suppose you find that Pharvaris has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Pharvaris regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pharvaris stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pharvaris stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pharvaris stock over time.
   Current vs Lagged Prices   
       Timeline  

Pharvaris Lagged Returns

When evaluating Pharvaris' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pharvaris stock have on its future price. Pharvaris autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pharvaris autocorrelation shows the relationship between Pharvaris stock current value and its past values and can show if there is a momentum factor associated with investing in Pharvaris BV.
   Regressed Prices   
       Timeline  

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Pharvaris Stock Analysis

When running Pharvaris' price analysis, check to measure Pharvaris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharvaris is operating at the current time. Most of Pharvaris' value examination focuses on studying past and present price action to predict the probability of Pharvaris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharvaris' price. Additionally, you may evaluate how the addition of Pharvaris to your portfolios can decrease your overall portfolio volatility.